Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …

Although pain treatment has been described as a fundamental human right, the Coronavirus
disease 2019 (COVID-19) pandemic forced healthcare systems worldwide to redistribute …

Chronic pain is associated with reduced quality of life, increased medical expenditures, and
significant economic costs. Chronic pain is among the most common chronic conditions in …

Given the rapid increase in the prevalence of chronic diseases in aging populations, this
prospective study including 17 707 adults aged≥ 45 years from China Health and …

A neuroimmune crosstalk is involved in somatic and visceral pathological pain including
inflammatory and neuropathic components. Apart from microglia essential for spinal and …

Background Globally, medical cannabis legalization has increased in recent years and
medical cannabis is commonly used to treat chronic pain. However, there are few …

Chronic pain can be recurrent or constant pain that lasts for longer than 3 months and can
result in disability, suffering, and a physical disturbance. Related to the complex nature of …

This systematic review and meta-analysis aims to identify and quantify the current available
evidence of hypnosis efficacy to manage pain in patients with chronic musculoskeletal and …

The 20% prevalence of chronic pain in the general population is a major health concern
given the often profound associated impairment of daily activities, employment status, and …

Nucleus-and cell-specific interrogation of individual basal forebrain (BF) cholinergic circuits
is crucial for refining targets to treat comorbid chronic pain-like and depression-like …